表纸
市场调查报告书

肌肉骨骼系统疾病用医药品的全球市场:类风湿性关节炎用医药品·肌肉松弛剂·其他

Musculoskeletal Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版商 The Business Research Company 商品编码 531332
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
肌肉骨骼系统疾病用医药品的全球市场:类风湿性关节炎用医药品·肌肉松弛剂·其他 Musculoskeletal Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出版日期: 2020年05月19日内容资讯: 英文
简介

本报告提供全球肌肉骨骼系统疾病用医药品的市场调查,提供市场定义和概要,市场的各种影响因素分析,各药物部门·各地各国趋势与市场规模的变化与预测,并汇整与宏觀经济因素·医疗保健市场全体·各种产业指标的比较,竞争环境,企业简介等资料。

第1章 市场特征

第2章 市场规模·成长率

  • 市场成长:迄今的过程
    • 成长推进因素
    • 阻碍成长要素
  • 市场成长:预测
    • 成长推进因素
    • 阻碍成长要素

第3章 大环境分析

第4章 客户资讯

第5章 肌肉骨骼系统疾病用医药品市场分析:各种类

  • 全球市场的实际成果:各种类
    • 类风湿性关节炎用医药品
    • 肌肉松弛剂
    • 其他
  • 全球市场的变化与预测:各种类
  • 市场趋势·策略

第6章 肌肉骨骼系统疾病用医药品市场分析:各地各国分析

  • 全球市场的实际成果:各地区
  • 全球市场的变化与预测:各地区
  • 市场实际成果:各国
  • 市场变化与预测:各国
  • 全球医药品市场实际成果:部门·各地区
  • 全球医药品市场实际成果:部门·各国

第7章 宏觀经济因素与市场比较

  • 市场规模的占 GDP的百分比
  • 平均每个人的平均支出额

第8章 宏觀经济因素与市场比较:各国

  • 市场规模的占 GDP的百分比:各国
  • 平均每个人的平均支出额:各国

第9章 产业指标与市场比较

  • 全球药剂师数:各国
  • 市场收益 vs 药剂师数:各国
  • 全球医药品公司数:各国
  • 市场收益 vs 医药品公司数:各国
  • 全球对R&D/产品开发的平均支出额:各国
  • 市场收益 vs 对R&D/产品开发的平均支出额:各国
  • 全球非专利&品牌销售额的比例:各国
  • 市场收益 vs 非专利&品牌销售额的比例:各国
  • 类风湿性关节炎的患病人数:各国
  • 全球一般开业医生数:各国
  • 市场收益 vs 一般开业医生数:各国

第10章 亚太地区市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 中国
  • 印度
  • 日本
  • 澳洲

第11章 西欧市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙

第12章 东欧市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 俄罗斯

第13章 北美市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 美国

第14章 南美市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 巴西

第15章 中东市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类

第16章 非洲市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类

第17章 竞争环境

  • 企业简介
  • Abbvie
  • Amgen
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.

第18章 主要M&A:肌肉骨骼系统疾病用医药品市场

第19章 市场背景:医药品市场

第20章 医药品产业的Financial Margins

第21章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

‘Musculoskeletal Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal disorders drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Musculoskeletal Disorders Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider musculoskeletal disorders drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The musculoskeletal disorders drugs market section of the report gives context. It compares the musculoskeletal disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: F. Hoffmann-La Roche Ltd; GlaxosmithKline Plc; Pfizer Inc; Abbott Laboratories Inc; Daiichi Sankyo Company

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Musculoskeletal Disorders Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Musculoskeletal Disorders Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Musculoskeletal Disorders Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Musculoskeletal Disorders Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Musculoskeletal Disorders Drugs Market Trends And Strategies

8. Musculoskeletal Disorders Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Musculoskeletal Disorders Drugs Market Regional Analysis

  • 9.1. Global Musculoskeletal Disorders Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Musculoskeletal Disorders Drugs Market Segmentation

  • 10.1. Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Drugs For Rheumatoid Arthritis

Muscle Relaxants

Others - Musculoskeletal Disorders Drugs

  • 10.2. Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Musculoskeletal Disorders Drugs Market Metrics

  • 11.1. Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Musculoskeletal Disorders Drugs Market

  • 12.1. Asia-Pacific Musculoskeletal Disorders Drugs Market Overview
  • 12.2. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Musculoskeletal Disorders Drugs Market Metrics
    • 12.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries
    • 12.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Asia-Pacific Countries
  • 12.6. Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Musculoskeletal Disorders Drugs Market: Country Analysis
    • 12.7.1. China Musculoskeletal Disorders Drugs Market
      • 12.7.1.1. China Musculoskeletal Disorders Drugs Market Overview
      • 12.7.1.2. China Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Musculoskeletal Disorders Drugs Market
      • 12.7.2.1. Australia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Musculoskeletal Disorders Drugs Market
      • 12.7.3.1. Hong Kong Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Musculoskeletal Disorders Drugs Market
      • 12.7.4.1. India Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Musculoskeletal Disorders Drugs Market
      • 12.7.5.1. Indonesia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Musculoskeletal Disorders Drugs Market
      • 12.7.6.1. Japan Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Musculoskeletal Disorders Drugs Market
      • 12.7.7.1. Malaysia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Musculoskeletal Disorders Drugs Market
      • 12.7.8.1. New Zealand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Musculoskeletal Disorders Drugs Market
      • 12.7.9.1. Philippines Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Musculoskeletal Disorders Drugs Market
      • 12.7.10.1. Singapore Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Musculoskeletal Disorders Drugs Market
      • 12.7.11.1. South Korea Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Musculoskeletal Disorders Drugs Market
      • 12.7.12.1. Thailand Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Musculoskeletal Disorders Drugs Market
      • 12.7.13.1. Vietnam Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Musculoskeletal Disorders Drugs Market

  • 13.1. Western Europe Musculoskeletal Disorders Drugs Market Overview
  • 13.2. Western Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Musculoskeletal Disorders Drugs Market Metrics
    • 13.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Western Europe Countries
    • 13.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Western Europe Countries
  • 13.6. Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Musculoskeletal Disorders Drugs Market: Country Analysis
    • 13.7.1. Austria Musculoskeletal Disorders Drugs Market
      • 13.7.1.1. Austria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Musculoskeletal Disorders Drugs Market
      • 13.7.2.1. Belgium Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Musculoskeletal Disorders Drugs Market
      • 13.7.3.1. Denmark Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Musculoskeletal Disorders Drugs Market
      • 13.7.4.1. Finland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Musculoskeletal Disorders Drugs Market
      • 13.7.5.1. France Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Musculoskeletal Disorders Drugs Market
      • 13.7.6.1. Germany Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Musculoskeletal Disorders Drugs Market
      • 13.7.7.1. Ireland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Musculoskeletal Disorders Drugs Market
      • 13.7.8.1. Italy Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Musculoskeletal Disorders Drugs Market
      • 13.7.9.1. Netherlands Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Musculoskeletal Disorders Drugs Market
      • 13.7.10.1. Norway Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Musculoskeletal Disorders Drugs Market
      • 13.7.11.1. Portugal Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Musculoskeletal Disorders Drugs Market
      • 13.7.12.1. Spain Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Musculoskeletal Disorders Drugs Market
      • 13.7.13.1. Sweden Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Musculoskeletal Disorders Drugs Market
      • 13.7.14.1. Switzerland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Musculoskeletal Disorders Drugs Market
      • 13.7.15.1. UK Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Musculoskeletal Disorders Drugs Market

  • 14.1. Eastern Europe Musculoskeletal Disorders Drugs Market Overview
  • 14.2. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Musculoskeletal Disorders Drugs Market Metrics
    • 14.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries
    • 14.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Eastern Europe Countries
  • 14.6. Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Musculoskeletal Disorders Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Musculoskeletal Disorders Drugs Market,
      • 14.7.1.1. Czech Republic Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Musculoskeletal Disorders Drugs Market
      • 14.7.2.1. Poland Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Musculoskeletal Disorders Drugs Market
      • 14.7.3.1. Romania Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Musculoskeletal Disorders Drugs Market
      • 14.7.4.1. Russia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Musculoskeletal Disorders Drugs Market

  • 15.1. North America Musculoskeletal Disorders Drugs Market Overview
  • 15.2. North America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Musculoskeletal Disorders Drugs Market Metrics
    • 15.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, North America Countries
    • 15.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, North America Countries
  • 15.6. North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Musculoskeletal Disorders Drugs Market: Country Analysis
    • 15.7.1. Canada Musculoskeletal Disorders Drugs Market
      • 15.7.1.1. Canada Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Musculoskeletal Disorders Drugs Market
      • 15.7.2.1. Mexico Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Musculoskeletal Disorders Drugs Market
      • 15.7.3.1. USA Musculoskeletal Disorders Drugs Market Overview
      • 15.7.3.2. USA Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Musculoskeletal Disorders Drugs Market

  • 16.1. South America Musculoskeletal Disorders Drugs Market Overview
  • 16.2. South America, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Musculoskeletal Disorders Drugs Market Metrics
    • 16.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, South America Countries
    • 16.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, South America Countries
  • 16.6. South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Musculoskeletal Disorders Drugs Market: Country Analysis
    • 16.7.1. Argentina Musculoskeletal Disorders Drugs Market
      • 16.7.1.1. Argentina Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Musculoskeletal Disorders Drugs Market
      • 16.7.1.1. Brazil Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Musculoskeletal Disorders Drugs Market
      • 16.7.3.1. Chile Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Musculoskeletal Disorders Drugs Market
      • 16.7.4.1. Colombia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Musculoskeletal Disorders Drugs Market
      • 16.7.5.1. Peru Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Musculoskeletal Disorders Drugs Market
      • 16.7.6.1. Venezuela Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Musculoskeletal Disorders Drugs Market

  • 17.1. Middle East Musculoskeletal Disorders Drugs Market Overview
  • 17.2. Middle East, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Musculoskeletal Disorders Drugs Market Metrics
    • 17.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Middle East Countries
    • 17.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Middle East Countries
  • 17.6. Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Musculoskeletal Disorders Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Musculoskeletal Disorders Drugs Market
      • 17.7.1.1. Saudi Arabia Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Musculoskeletal Disorders Drugs Market
      • 17.7.2.1. Israel Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Musculoskeletal Disorders Drugs Market
      • 17.7.3.1. Turkey Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Musculoskeletal Disorders Drugs Market
      • 17.7.4.1. UAE Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Musculoskeletal Disorders Drugs Market

  • 18.1. Africa Musculoskeletal Disorders Drugs Market Overview
  • 18.2. Africa, Musculoskeletal Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Musculoskeletal Disorders Drugs Market Metrics
    • 18.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2015-2023, Africa Countries
    • 18.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2019, Africa Countries
  • 18.6. Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Musculoskeletal Disorders Drugs Market: Country Analysis
    • 18.7.1. Egypt Musculoskeletal Disorders Drugs Market
      • 18.7.1.1. Egypt Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Musculoskeletal Disorders Drugs Market
      • 18.7.2.1. Nigeria Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Musculoskeletal Disorders Drugs Market
      • 18.7.3.1. South Africa Musculoskeletal Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Musculoskeletal Disorders Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. F. Hoffmann-La Roche Ltd
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. GlaxosmithKline Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Pfizer Inc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Abbott Laboratories Inc
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Daiichi Sankyo Company
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Musculoskeletal Disorders Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Countries
  • 22.2. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Segments
  • 22.3. Global Musculoskeletal Disorders Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer